A carregar...
Assessment of romiplostim immunogenicity in adult patients in clinical trials and in a global postmarketing registry
Antibodies to first‐generation recombinant thrombopoietin (TPO) neutralized endogenous TPO and caused thrombocytopenia in some healthy subjects and chemotherapy patients. The second‐generation TPO receptor agonist romiplostim, having no sequence homology to TPO, was developed to avoid immunogenicity...
Na minha lista:
| Publicado no: | Br J Haematol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7540503/ https://ncbi.nlm.nih.gov/pubmed/32311075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16658 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|